UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 120

Sortiert nach

Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes

The New England journal of medicine, 2017-09, Vol.377 (13), p.1228-1239

2017

Volltextzugriff (PDF)

The economic costs of progressive supranuclear palsy and multiple system atrophy in France, Germany and the United Kingdom

Plant methods, 2011-09, Vol.6 (9), p.e24369-e24369

2011

Volltextzugriff (PDF)

Hip fracture trends in the United States, 2002 to 2015

Osteoporosis international, 2018-03, Vol.29 (3), p.717-722

2018

Volltextzugriff (PDF)

Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial

Journal of clinical oncology, 2012-01, Vol.30 (2), p.134-141

2012

Volltextzugriff (PDF)

Frequency and Risk Factors Associated With Osteonecrosis of the Jaw in Cancer Patients Treated With Intravenous Bisphosphonates

Journal of bone and mineral research, 2008-06, Vol.23 (6), p.826-836

2008

Volltextzugriff (PDF)

Vandetanib for the Treatment of Patients With Locally Advanced or Metastatic Hereditary Medullary Thyroid Cancer

Journal of clinical oncology, 2010-02, Vol.28 (5), p.767-772

2010

Volltextzugriff (PDF)

Activity of XL184 (Cabozantinib), an Oral Tyrosine Kinase Inhibitor, in Patients With Medullary Thyroid Cancer

Journal of clinical oncology, 2011-07, Vol.29 (19), p.2660-2666

2011

Volltextzugriff (PDF)

Bisphosphonate‐Associated Osteonecrosis of the Jaw: Report of a Task Force of the American Society for Bone and Mineral Research

Journal of bone and mineral research, 2007-10, Vol.22 (10), p.1479-1491

2007

Volltextzugriff (PDF)

The Characterization of Pheochromocytoma and Its Impact on Overall Survival in Multiple Endocrine Neoplasia Type 2

The journal of clinical endocrinology and metabolism, 2013-11, Vol.98 (11), p.E1813-E1819

2013

Volltextzugriff (PDF)

Safety and efficacy of two starting doses of vandetanib in advanced medullary thyroid cancer

Endocrine-related cancer, 2019-02, Vol.26 (2), p.241-250

2019

Volltextzugriff (PDF)

Epidemiology and risk factors for osteonecrosis of the jaw in cancer patients

Annals of the New York Academy of Sciences, 2011-02, Vol.1218 (1), p.47-54

2011

Volltextzugriff (PDF)

Phase I Trial of a Combination of the Multikinase Inhibitor Sorafenib and the Farnesyltransferase Inhibitor Tipifarnib in Advanced Malignancies

Clinical cancer research, 2009-11, Vol.15 (22), p.7061-7068

2009

Volltextzugriff (PDF)

Medullary Thyroid Carcinoma in MEN2A: ATA Moderate- or High-Risk RET Mutations Do Not Predict Disease Aggressiveness

The journal of clinical endocrinology and metabolism, 2017-08, Vol.102 (8), p.2807-2813

2017

Volltextzugriff (PDF)

Calcitonin Plays a Critical Role in Regulating Skeletal Mineral Metabolism during Lactation

Endocrinology (Philadelphia), 2006-09, Vol.147 (9), p.4010-4021

2006

Volltextzugriff (PDF)

ATF4 Targets RET for Degradation and is a Candidate Tumor Suppressor Gene in Medullary Thyroid Cancer

The journal of clinical endocrinology and metabolism, 2017-03, Vol.102 (3), p.933-941

2017

Volltextzugriff (PDF)

Management of Pancreatic Endocrine Tumors in Multiple Endocrine Neoplasia Type 1

World journal of surgery, 2006-05, Vol.30 (5), p.643-653

2006

Volltextzugriff (PDF)

My, How Things Have Changed in Multiple Endocrine Neoplasia Type 2A

The journal of clinical endocrinology and metabolism, 2015-07, Vol.100 (7), p.2532-2535

2015

Volltextzugriff (PDF)

Management of Osteoporosis in Survivors of Adult Cancers With Nonmetastatic Disease: ASCO Clinical Practice Guideline

Journal of clinical oncology, 2019-11, Vol.37 (31), p.2916-2946

2019

Volltextzugriff (PDF)

ASCO/SSO Review of Current Role of Risk-Reducing Surgery in Common Hereditary Cancer Syndromes

Journal of clinical oncology, 2006-10, Vol.24 (28), p.4642-4660

2006

Volltextzugriff (PDF)

Increased bone mass is an unexpected phenotype associated with deletion of the calcitonin gene

The Journal of clinical investigation, 2002-12, Vol.110 (12), p.1849-1857

2002

Volltextzugriff (PDF)

Glucose Homeostasis and Safety in Patients with Acromegaly Converted from Long-Acting Octreotide to Pegvisomant

The journal of clinical endocrinology and metabolism, 2005-10, Vol.90 (10), p.5684-5691

2005

Volltextzugriff (PDF)

Changes in Serum Calcitonin Concentrations, Incidence of Medullary Thyroid Carcinoma, and Impact of Routine Calcitonin Concentration Monitoring in the EXenatide Study of Cardiovascular Event Lowering (EXSCEL)

Diabetes care, 2019-06, Vol.42 (6), p.1075-1080

2019

Volltextzugriff (PDF)

Role of CDKN2C Copy Number in Sporadic Medullary Thyroid Carcinoma

Thyroid (New York, N.Y.), 2016-11, Vol.26 (11), p.1553

2016

Volltextzugriff (PDF)

Association between Body Mass Index, C-Reactive Protein Levels, and Melanoma Patient Outcomes

Journal of investigative dermatology, 2017-08, Vol.137 (8), p.1792-1795

2017

Volltextzugriff (PDF)

What is the Optimal Low-Density Lipoprotein Cholesterol?

The Medical clinics of North America, 2022-03, Vol.106 (2), p.285-298

2022

Volltextzugriff (PDF)

1 – 25 von 120

Suche als RSS-Feed

Aktive Filter

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(114)
Mit Volltextzugriff
(94)

Publikationsform

Artikel
(120)

Sprache

Englisch
(117)
Japanisch
(21)
Deutsch
(2)
Spanisch
(1)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes

The economic costs of progressive supranuclear palsy and multiple system atrophy in France, Germany and the United Kingdom

Hip fracture trends in the United States, 2002 to 2015

Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial

Frequency and Risk Factors Associated With Osteonecrosis of the Jaw in Cancer Patients Treated With Intravenous Bisphosphonates

Vandetanib for the Treatment of Patients With Locally Advanced or Metastatic Hereditary Medullary Thyroid Cancer

Activity of XL184 (Cabozantinib), an Oral Tyrosine Kinase Inhibitor, in Patients With Medullary Thyroid Cancer

Bisphosphonate‐Associated Osteonecrosis of the Jaw: Report of a Task Force of the American Society for Bone and Mineral Research

The Characterization of Pheochromocytoma and Its Impact on Overall Survival in Multiple Endocrine Neoplasia Type 2

Safety and efficacy of two starting doses of vandetanib in advanced medullary thyroid cancer

Epidemiology and risk factors for osteonecrosis of the jaw in cancer patients

Phase I Trial of a Combination of the Multikinase Inhibitor Sorafenib and the Farnesyltransferase Inhibitor Tipifarnib in Advanced Malignancies

Medullary Thyroid Carcinoma in MEN2A: ATA Moderate- or High-Risk RET Mutations Do Not Predict Disease Aggressiveness

Calcitonin Plays a Critical Role in Regulating Skeletal Mineral Metabolism during Lactation

ATF4 Targets RET for Degradation and is a Candidate Tumor Suppressor Gene in Medullary Thyroid Cancer

Management of Pancreatic Endocrine Tumors in Multiple Endocrine Neoplasia Type 1

My, How Things Have Changed in Multiple Endocrine Neoplasia Type 2A

Management of Osteoporosis in Survivors of Adult Cancers With Nonmetastatic Disease: ASCO Clinical Practice Guideline

ASCO/SSO Review of Current Role of Risk-Reducing Surgery in Common Hereditary Cancer Syndromes

Increased bone mass is an unexpected phenotype associated with deletion of the calcitonin gene

Glucose Homeostasis and Safety in Patients with Acromegaly Converted from Long-Acting Octreotide to Pegvisomant

Changes in Serum Calcitonin Concentrations, Incidence of Medullary Thyroid Carcinoma, and Impact of Routine Calcitonin Concentration Monitoring in the EXenatide Study of Cardiovascular Event Lowering (EXSCEL)

Role of CDKN2C Copy Number in Sporadic Medullary Thyroid Carcinoma

Association between Body Mass Index, C-Reactive Protein Levels, and Melanoma Patient Outcomes

What is the Optimal Low-Density Lipoprotein Cholesterol?

Aktive Filter

Suchergebnisse filtern